Oral antivirals for mild-moderate COVID-19: a panacea or a logistical and clinical conundrum?

被引：2
|
作者：
Coombes, Ian D. [1 ,2 ,3 ]
Legg, Amy [1 ,3 ,4 ,6 ]
Patterson, Tina [3 ,5 ,6 ]
Kelly, Tanya [3 ,7 ,8 ]
Henderson, Andrew [3 ,5 ,9 ]
Roberts, Jason A. [1 ,3 ,4 ,10 ,11 ]
机构：
[1] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld, Australia
[2] Univ Queensland, Dept Pharm, Brisbane, Qld, Australia
[3] COVID 19 Med Pharm Planning & Response Grp, Brisbane, Qld, Australia
[4] Metro North Hlth, Herston Infect Dis Inst HeIDI, Brisbane, Qld, Australia
[5] COVID 19 Clin Therapeut Guideline Working Grp, Brisbane, Qld, Australia
[6] Logan Hosp, Dept Pharm, Brisbane, Qld, Australia
[7] Sunshine Coast Univ Hosp, Dept Anaesthesia & Perioperat Med, Sunshine Coast, Qld, Australia
[8] Queensland Clin Senate, Clin Excellence Queensland, Brisbane, Qld, Australia
[9] Princess Alexandra Hosp, Dept Infect Dis, Brisbane, Qld, Australia
[10] Univ Queensland, Fac Med, Ctr Clin Res, Brisbane, Qld, Australia
[11] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia
来源：
AUSTRALIAN PRESCRIBER | 2022年 / 45卷 / 02期
关键词：
COVID-19; molnupiravir; nirmatrelvir/ritonavir; quality use of medicines; SARS-CoV-2;
D O I：
10.18773/austprescr.2022.021
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
  • [1] Corticosteroids prescription for mild-moderate COVID-19 in Primary Care
    Ordinola Navarro, Alberto
    Lopez Luis, Bruno Ali
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2021, 15 (12): : 1813 - 1815
  • [2] Clinical Characteristics of Mild-Moderate COVID-19 Patients and Risk Factors for the Development of Pneumonia
    Ozdemir, Yusuf Emre
    Balkan, Ilker Inanc
    Bayramlar, Osman Faruk
    Alkan, Sena
    Murt, Ahmet
    Karaali, Ridvan
    Mete, Bilgul
    Kuskucu, Mert Ahmet
    Aygun, Gokhan
    Keskindemirci, Yilmaz
    Ongoren, Seniz
    Kutlubay, Zekayi
    Cetinkale, Oguz
    Saltoglu, Nese
    Tabak, Fehmi
    MIKROBIYOLOJI BULTENI, 2021, 55 (03): : 342 - 356
  • [3] Monoclonal Antibody Infusions for Outpatient Management of Mild-Moderate COVID-19
    Knox, Hannah B.
    Dykes, Lisa A.
    Scott, Lancer A.
    Presley, Bradley C.
    Lambert, Lara C.
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (10) : 985 - 993
  • [4] Cognitive impairment in people with COVID-19 with mild-moderate symptoms in Ecuador
    Checa, Alejandro
    Navas, Eliana
    Valencia, Veronica
    Alcivar, Jessica
    REVISTA MEXICANA DE NEUROCIENCIA, 2022, 23 (04): : 126 - 129
  • [5] Oral antivirals for COVID-19 among patients with cancer
    Guermazi, Dorra
    Arvanitis, Panos
    Vieira, Kendra
    Warner, Jeremy L.
    Farmakiotis, Dimitrios
    SUPPORTIVE CARE IN CANCER, 2024, 32 (08)
  • [6] Artificial intelligence for diagnosis of mild-moderate COVID-19 using haematological markers
    Chadaga, Krishnaraj
    Prabhu, Srikanth
    Bhat, Vivekananda
    Sampathila, Niranjana
    Umakanth, Shashikiran
    Chadaga, Rajagopala
    ANNALS OF MEDICINE, 2023, 55 (01)
  • [7] Decreased quality of life and spirometric alterations even after mild-moderate COVID-19
    Navarro, Alberto Ordinola
    Cervantes-Bojalil, Javier
    Cobos Quevedo, Orestes de Jesus
    Avila Martinez, Andrea
    Alberto Hernandez-Jimenez, Carlos
    Perez Alvarez, Esperanza
    Gonzalez Gil, Andrea
    Peralta Amaro, Ana Lilia
    Vera-Lastra, Olga
    Lopez Luis, Bruno Ali
    RESPIRATORY MEDICINE, 2021, 181
  • [8] Mild or Moderate Covid-19
    Gandhi, Rajesh T.
    Lynch, John B.
    del Rio, Carlos
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18) : 1757 - 1766
  • [9] Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild-Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir
    Bai, Francesca
    Beringheli, Tomaso
    Vitaletti, Virginia
    Santoro, Andrea
    Mola, Francesco
    Copes, Alessandro
    Gemignani, Nicole
    Pettenuzzo, Sofia
    Castoldi, Roberto
    Varisco, Benedetta
    Nardo, Riccardo
    Lundgren, Lorenzo Brando
    Ligresti, Riccardo
    Sala, Matteo
    Albertini, Lorenzo
    Augello, Matteo
    Biasioli, Lorenzo
    Bono, Valeria
    Rovito, Roberta
    Bini, Teresa
    Passarella, Sabrina
    Orfeo, Nicola Vincenzo
    Monforte, Antonella d'Arminio
    Marchetti, Giulia
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (07) : 1589 - 1605
  • [10] Mid-term impact of mild-moderate COVID-19 on cardiorespiratory fitness in elite athletes
    Anastasio, Fabio
    LA Macchia, Tommaso
    Rossi, Giulio
    D'abbondanza, Marco
    Curcio, Rosa
    Vaudo, Gaetano
    Pucci, Giacomo
    JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS, 2022, 62 (10) : 1383 - 1390
12345